The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
RNS Number : 3826U Sareum Holdings PLC 23 November 2023
Sareum Holdings PLC ("Sareum" or the "Company")
Drawdown of Equity Prepayment Facility
Cambridge, UK, 23 November 2023 - Sareum Holdings plc (AIM: SAR), a biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, announces that it has drawn down on the £0.3 million Second Deposit in respect of the Equity Prepayment Facility announced on 3 August 2023.
In accordance with the terms of the Equity Prepayment Facility, the Company will issue 227,892 four year warrants over ordinary shares of 1.25p each exercisable at a price of £0.829337 to Riverfort.
Unless otherwise defined herein, all capitalised terms in this announcement shall have the meanings assigned to them in the Company's announcements of 3
August 2023.
Hi Numan. If you think "Patel" was the most accurate poster on this board can I assume you are shorting the stock at the moment? I can't believe you are long based on your negative view of the SP so perhaps you would let me know your thinking?
Hi Numan. If you think "Patel" was the most accurate poster on this board can I assume you are shorting the stock at the moment? I can't believe you are long based on your negative view of the SP so perhaps you would let me know your thinking?
Hi Numan. If you think "Patel" was the most accurate poster on this board can I assume you are shorting the stock at the moment? I can't believe you are long based on your negative view of the SP so perhaps you would let me know your thinking?